SOUTH SAN FRANCISCO, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM), formerly ViroLogic, Inc., announced today that William D. Young, CEO and Chairman of...
Conference Call Scheduled for 4:30 p.m. Eastern Today SO. SAN FRANCISCO, Calif., Sept. 6 /PRNewswire-FirstCall/ -- ViroLogic, Inc., (NASDAQ:VLGC) announced today that it is changing its name to...
SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) today announced the appointment of William J. Welch as Senior Vice President and Chief Commercial...
ViroLogic Announces Second Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC), announced that it will...
ViroLogic Announces Second Quarter 2005 Financial Results - HIV clinical trials provide boost to testing revenues - 35% revenue growth - SOUTH SAN FRANCISCO, Calif., July 25...
ViroLogic Announces Second Quarter 2005 Financial Results Conference Call SOUTH SAN FRANCISCO, Calif., July 19 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC), announced that it will...
ViroLogic Announces Multi-Year Service Agreement With Schering-Plough to Support New HIV Drug Discovery and Development Efforts SOUTH SAN FRANCISCO, Calif., July 6 /PRNewswire-FirstCall/...
ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference SO. SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) announced today...
ViroLogic Added to the NASDAQ Biotechnology Index SOUTH SAN FRANCISCO, Calif., May 20 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) announced today that it will be added to the NASDAQ...
ViroLogic's eTag System Demonstrates Potential Ability to Better Select Breast Cancer Patients for Therapy With Herceptin -Abstract #553- ORLANDO, Fla., May 17 /PRNewswire-FirstCall/...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約